Press Releases from RE.DOCTOR (4 total)
RE.DOCTOR Vitals Revolutionizes Healthcare in the Kingdom of Saudi Arabia with I …
Riyadh, Saudi Arabia - RE.DOCTOR Vitals, a leading healthcare technology company, is proud to announce the launch of its latest features in the Kingdom of Saudi Arabia. The new features are designed to enhance patient care, streamline clinical workflows, and improve overall health outcomes.
"We are thrilled to bring these cutting-edge innovations to the healthcare community in Saudi Arabia," said Simon Halliday, CEO of RE.DOCTOR Vitals. "Our goal is to empower…
RE.DOCTOR LLC Achieves ISO 13485 Certification, Highlighting Commitment to Quali …
RE.DOCTOR LLC, a leading developer of innovative medical devices, today announced it has achieved ISO 13485:2016 certification. This internationally recognized standard signifies RE.DOCTOR's commitment to a robust quality management system (QMS) throughout the entire lifecycle of its medical devices, from conception and design to production, distribution, and servicing.
ISO 13485 certification demonstrates RE.DOCTOR's dedication to:
Meeting regulatory requirements: The certification ensures RE.DOCTOR adheres to the highest quality standards set forth by regulatory…
Collecting Physiologic Data for Health and Life Insurance Risk Assessment
RE.DOCTOR is pleased to announce the launch of our innovative Vital Signs Monitor software development kit (SDK). This cutting-edge technology allows insurance carriers to integrate vital signs monitoring into their mobile applications, collecting real-time physiologic data to enhance risk assessment and policyholder experience.
By measuring indicators such as heart rate, blood pressure, respiratory rate and temperature, insurers gain valuable insights into policyholder health and wellness over time. This data-driven approach…
Non-Invasive Blood Glucose Monitoring Developed by RE.DOCTOR
RE.DOCTOR through its development of Non-Invasive Blood Glucose Monitoring (BGM) has engineered a pre-diabetes solution that is non-invasive, easily accessible, and low cost.
Diabetes and it's related outcomes are expected to be a significant problem worldwide, with a projected 1 in 2 diabetic patients being undiagnosed by 2030.
The potential to vastly enhance chronic illness management such as Type 2 Diabetes Mellitus (T2DM) is still largely untapped.
Simon Censon, Cofounder of RE.DOCTOR stated,…
